{
  "cik": 1761918,
  "cik_padded": "0001761918",
  "entityName": "Erasca, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-104150",
      "filed": "2026-03-12",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 128000.0,
        "cash": 73805000.0,
        "eps_diluted": -0.44,
        "free_cash_flow": -95583000.0,
        "net_income": -124546000.0,
        "operating_cash_flow": -95455000.0,
        "operating_income": -140905000.0,
        "stockholders_equity": 325171000.0,
        "total_assets": 396154000.0,
        "total_liabilities": 70983000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.21829437434457563,
        "roa_avg2y": -0.27717541282770286,
        "roa_period_end": -0.31438783907268386,
        "roe_avg2y": -0.3327126771474749,
        "roe_period_end": -0.3830169357045985
      }
    },
    {
      "accn": "0001193125-26-104150",
      "filed": "2026-03-12",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 60000.0,
        "cash": 67739000.0,
        "eps_diluted": -0.69,
        "free_cash_flow": -109477000.0,
        "net_income": -161650000.0,
        "operating_cash_flow": -109417000.0,
        "operating_income": -179587000.0,
        "stockholders_equity": 423499000.0,
        "total_assets": 502526000.0,
        "total_liabilities": 79027000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1866049270482339,
        "roa_avg2y": -0.3600932477782369,
        "roa_period_end": -0.32167489841321645,
        "roe_avg2y": -0.43678269621783744,
        "roe_period_end": -0.3817010193648628
      }
    },
    {
      "accn": "0001193125-26-104150",
      "filed": "2026-03-12",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1775000.0,
        "cash": 93075000.0,
        "eps_diluted": -0.83,
        "free_cash_flow": -102992000.0,
        "net_income": -125042000.0,
        "operating_cash_flow": -101217000.0,
        "operating_income": -141525000.0,
        "stockholders_equity": 316686000.0,
        "total_assets": 395297000.0,
        "total_liabilities": 78611000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.24823010805656076,
        "roa_avg2y": -0.27475538504470415,
        "roa_period_end": -0.3163241815647475,
        "roe_avg2y": -0.34326782780331594,
        "roe_period_end": -0.3948453673354679
      }
    },
    {
      "accn": "0000950170-25-042682",
      "filed": "2025-03-20",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 14551000.0,
        "cash": 284217000.0,
        "eps_diluted": -1.99,
        "free_cash_flow": -117815000.0,
        "net_income": -242805000.0,
        "operating_cash_flow": -103264000.0,
        "operating_income": -247450000.0,
        "stockholders_equity": 411853000.0,
        "total_assets": 514909000.0,
        "total_liabilities": 103056000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.250225201710319,
        "roa_avg2y": -0.47781022587285155,
        "roa_period_end": -0.47154934172834423,
        "roe_avg2y": -0.5592130643116328,
        "roe_period_end": -0.5895428708786873
      }
    },
    {
      "accn": "0000950170-24-037193",
      "filed": "2024-03-27",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 11205000.0,
        "cash": 360487000.0,
        "eps_diluted": -1.85,
        "free_cash_flow": -90805000.0,
        "net_income": -122764000.0,
        "operating_cash_flow": -79600000.0,
        "operating_income": -124883000.0,
        "stockholders_equity": 456528000.0,
        "total_assets": 501415000.0,
        "total_liabilities": 44887000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.09832255633827498,
        "roa_avg2y": -0.3920669391926418,
        "roa_period_end": -0.2448351166199655,
        "roe_avg2y": -0.7167779905647158,
        "roe_period_end": -0.2689079311674202
      }
    },
    {
      "accn": "0000950170-23-009496",
      "filed": "2023-03-23",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 947000.0,
        "cash": 65376000.0,
        "free_cash_flow": -33633000.0,
        "net_income": -101660000.0,
        "operating_cash_flow": -32686000.0,
        "operating_income": -109252000.0,
        "stockholders_equity": -113984000.0,
        "total_assets": 124825000.0,
        "total_liabilities": 17404000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.814420188263569,
        "roe_avg2y": 1.59356679311534
      }
    },
    {
      "accn": "0000950170-22-004557",
      "filed": "2022-03-24",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -13604000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-104150",
    "filed": "2026-03-12",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001761918.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001761918.json"
  },
  "ticker": "ERAS"
}